RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

44 hedge funds and large institutions have $18.7M invested in Regulus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 12 closing their positions.

Holders
44
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
14
Reduced
4
Closed
12
Calls
$376K
Puts
$343K
Net Calls
+$33K
Net Calls Change
-$535K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$406K
2
Citadel Advisors
2
Citadel Advisors
Florida
$227K
3
ECM
3
Endurant Capital Management
California
$2.12M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$479K
5
GCP
5
GSA Capital Partners
United Kingdom
$168K

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$0
4
AI
4
Atom Investors
Texas
$0
5
ACM
5
Asymmetry Capital Management
California
$1.18M
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
51
Goldman Sachs
New York
– -$28K -1,805 Closed
PAG
52
Private Advisor Group
New Jersey
– -$16K -1,000 Closed
VFA
53
Valeo Financial Advisors
Indiana
– -$7K -423 Closed
CA
54
Clearstead Advisors
Ohio
– -$2K -100 Closed
FDCDDQ
55
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$129 -8 Closed
1 2
3